Shanghai Shyndec Pharmaceutical バランスシートの健全性
財務の健全性 基準チェック /66
Shanghai Shyndec Pharmaceutical has a total shareholder equity of CN¥15.2B and total debt of CN¥1.1B, which brings its debt-to-equity ratio to 7.1%. Its total assets and total liabilities are CN¥20.1B and CN¥4.9B respectively. Shanghai Shyndec Pharmaceutical's EBIT is CN¥1.5B making its interest coverage ratio -12.5. It has cash and short-term investments of CN¥5.6B.
主要情報
7.1%
負債資本比率
CN¥1.08b
負債
| インタレスト・カバレッジ・レシオ | -12.5x |
| 現金 | CN¥5.64b |
| エクイティ | CN¥15.19b |
| 負債合計 | CN¥4.87b |
| 総資産 | CN¥20.07b |
財務の健全性に関する最新情報
更新なし
Recent updates
財務状況分析
短期負債: 600420's short term assets (CN¥11.6B) exceed its short term liabilities (CN¥4.6B).
長期負債: 600420's short term assets (CN¥11.6B) exceed its long term liabilities (CN¥254.9M).
デット・ツー・エクイティの歴史と分析
負債レベル: 600420 has more cash than its total debt.
負債の削減: 600420's debt to equity ratio has reduced from 46.9% to 7.1% over the past 5 years.
債務返済能力: 600420's debt is well covered by operating cash flow (212.6%).
インタレストカバレッジ: 600420 earns more interest than it pays, so coverage of interest payments is not a concern.